Ontology highlight
ABSTRACT:
SUBMITTER: Mirman Z
PROVIDER: S-EPMC6938671 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
53BP1 is an enigmatic DNA damage response factor that gained prominence because it determines the efficacy of PARP1 inhibitory drugs (PARPi) in BRCA1-deficient cancers. Recent studies have elevated 53BP1 from its modest status of (yet another) DNA damage factor to master regulator of double-strand break (DSB) repair pathway choice. Our review of the literature suggests an alternative view. We propose that 53BP1 has evolved to avoid mutagenic repair outcomes and does so by controlling the process ...[more]